{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:24:05Z","timestamp":1750533845508},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Within 48 hours after surgery, disease assessment in glioblastoma is a challenge for both the clinician and the radiologist. Certain technical and logistical issues prevail in this period. <jats:sup>68<\/jats:sup>Ga\u2013prostate-specific membrane antigen PET\/CT is a known molecular imaging marker in prostate cancer. Its role in high-grade gliomas has been recently discussed. We present a case of a 39-year-old man with recurrence glioblastoma of the right frontal lobe and underwent resurgery. After surgery, <jats:sup>68<\/jats:sup>Ga\u2013prostate-specific membrane antigen PET\/CT showed residual disease along the posterior and inferior margin of the postoperative cavity.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002893","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T16:43:41Z","timestamp":1579884221000},"page":"204-205","source":"Crossref","is-referenced-by-count":6,"title":["Role of 68Ga\u2013Prostate-Specific Membrane Antigen PET\/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery"],"prefix":"10.1097","volume":"45","author":[{"given":"Manoj","family":"Gupta","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha Sarathi","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishwar Chandra","family":"Premsagar","sequence":"additional","affiliation":[{"name":"Neuro & Spine Oncology Services"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munish","family":"Gairola","sequence":"additional","affiliation":[{"name":"Radiotherapy, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parveen","family":"Ahlawat","sequence":"additional","affiliation":[{"name":"Radiotherapy, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"bib1-20230925","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","year":"1997","journal-title":"Clin Cancer Res"},{"key":"bib2-20230925","first-page":"3192","article-title":"Five different anti\u2013prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature","volume":"59","year":"1999","journal-title":"Cancer Res"},{"key":"bib3-20230925","first-page":"2674","article-title":"Prostate-specific membrane antigen is produced in tumor-associated neovasculature","volume":"5","year":"1999","journal-title":"Clin Cancer Res"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-14-26","article-title":"Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases","volume":"14","year":"2014","journal-title":"Cancer Cell Int"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1097\/RLU.0000000000002175","article-title":"Utility of 68Ga-PSMA-11 PET\/CT in imaging of glioma\u2014a pilot study","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0971-3026.155829","article-title":"Post-treatment imaging of high-grade gliomas","volume":"25","year":"2015","journal-title":"Indian J Radiol Imaging"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/neuonc\/nor054","article-title":"Molecular imaging of gliomas with PET: opportunities and limitations","volume":"13","year":"2011","journal-title":"Neuro Oncol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cpet.2013.02.001","article-title":"Overview of PET tracers for brain tumor imaging","volume":"8","year":"2013","journal-title":"PET Clin"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:10:52Z","timestamp":1695622252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002893","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}